Do maternal opioids reduce neonatal regional brain volumes? A pilot study

Area of Science:

• Neuroscience
• Developmental Pediatrics
• Radiology

Background:

• Gestational opioid exposure is linked to adverse neurodevelopmental, behavioral, and cognitive outcomes in children.
• While not direct neuroteratogens, subtle effects of opioids on the developing brain, such as volume alterations, remain under investigation.

Purpose of the Study:

• To assess the feasibility of using magnetic resonance imaging (MRI) to detect volumetric changes in the brains of infants exposed to opioids during gestation.
• To investigate potential subtle brain volume differences in healthy opioid-exposed infants.

Main Methods:

• An observational pilot cohort study was conducted in two maternity hospitals in New South Wales, Australia.
• Maternal drug exposure was confirmed via medical history and neonatal urine/meconium screens.
• Volumetric analysis of MRI scans was performed using the ITK-snap program.

Main Results:

• MRI scans of 16 opioid-exposed infants were analyzed.
• Whole brain volumes and basal ganglia volumes were significantly smaller than population means.
• Lateral ventricular volumes were larger than population values, despite structurally normal scans.

Conclusions:

• This pilot study suggests that opioid-exposed infants may exhibit reduced brain volumes, with the basal ganglia being a potentially affected region.
• Larger studies are warranted to confirm these volumetric findings and correlate them with neurodevelopmental outcomes in opioid-exposed children.